Physician profile
Marc Erickson
NPI 1265939268
$21,410.53
in general payments reported to CMS, 2019-2025
19 companies · $13K in 2025
The $13K reported for 2025 was more than what 99% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $28.33 · 2022: $729 · 2023: $677 · 2024: $6,854 · 2025: $13K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $10K · Food and Beverage: $5,545 · Travel and Lodging: $4,527 · Education: $581.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $10,000.00 |
| Food and Beverage | $5,545.34 |
| Travel and Lodging | $4,526.78 |
| Education | $580.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $12,819.17 | 2022-2025 | Micra, Pulseselect, Linq II |
| Boston Scientific Corporation | $2,965.34 | 2022-2025 | Accolade Sr, Farapulse, Resonate El Icd Vr |
| Biotronik INC. | $2,664.49 | 2024-2025 | Acticor 7 Vr-T Dx, Amvia Edge |
| Abbott Laboratories | $802.43 | 2024-2025 | Ensite, Thoratec Heartmate 3 Lvas Implant Kit, Aveir |
| Biosense Webster, INC. | $679.49 | 2024-2025 | Carto 3 |
| E.R. Squibb & Sons, L.L.C. | $345.81 | 2022-2023 | Camzyos |
| Boehringer Ingelheim Pharmaceuticals, INC. | $229.82 | 2021-2024 | Jardiance |
| Abiomed | $210.15 | 2024 | Impella |
| Sanofi-Aventis U.S. LLC | $141.90 | 2023-2024 | |
| Shockwave Medical, INC | $129.55 | 2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Edwards Lifesciences Corporation | $103.32 | 2024 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Pfizer INC. | $76.59 | 2022-2023 | |
| Astrazeneca Pharmaceuticals LP | $59.26 | 2021-2023 | Farxiga |
| Merck Sharp & Dohme LLC | $48.34 | 2023 | Verquvo |
| Lantheus Medical Imaging, INC. | $46.50 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lexicon Pharmaceuticals, INC. | $34.50 | 2023 | Inpefa |
| Cardiva Medical, INC. | $26.30 | 2023 | Cardiva Vascade Mvp Vvcs 6-12f |
| Janssen Pharmaceuticals, INC | $15.16 | 2024 | Xarelto |
| Alexion Pharmaceuticals, INC. | $12.41 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marc Erickson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.